We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$768M
AUM Growth
+$22.8M
Cap. Flow
+$26.3M
Cap. Flow %
3.42%
Top 10 Hldgs %
13.16%
Holding
1,093
New
800
Increased
114
Reduced
121
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.93M
2
CACI icon
CACI
CACI
+$5.05M
3
CELG
Celgene Corp
CELG
+$4.9M
4
YELP icon
Yelp
YELP
+$4.72M
5
NSC icon
Norfolk Southern
NSC
+$4.51M

Top Sells

Rank Stock Value
1
TDC icon
Teradata
TDC
+$6.01M
2
GILD icon
Gilead Sciences
GILD
+$5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.91M
4
CPA icon
Copa Holdings
CPA
+$4.6M
5
LOW icon
Lowe's Companies
LOW
+$4.43M

Sector Composition

Rank Sector Weight
1 Financials 17.19%
2 Technology 14.55%
3 Healthcare 13.55%
4 Industrials 12.49%
5 Consumer Discretionary 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
401
Intuitive Surgical
ISRG
$134B
$66K 0.01%
+480
New +$67K
MRSH
402
Marsh
MRSH
$91.5B
$66K 0.01%
+793
New +$65.7K
STZ icon
403
Constellation Brands
STZ
$23.2B
$65K 0.01%
+283
New +$62.3K
KMI icon
404
Kinder Morgan
KMI
$68.7B
$64K 0.01%
+4,244
New +$73.5K
NUE icon
405
Nucor
NUE
$62.1B
$64K 0.01%
+1,046
New +$69.3K
VSH icon
406
Vishay Intertechnology
VSH
$5.43B
$64K 0.01%
3,458
-221,307
-98% -$4.43M
ALXN
407
DELISTED
Alexion Pharmaceuticals
ALXN
$64K 0.01%
+575
New +$68.7K
APH icon
408
Amphenol
APH
$209B
$62K 0.01%
+2,860
New +$64.4K
WHR icon
409
Whirlpool
WHR
$2.82B
$62K 0.01%
+407
New +$68K
FISV
410
Fiserv Inc
FISV
$27.9B
$61K 0.01%
+855
New +$60.1K
OXY icon
411
Occidental Petroleum
OXY
$55.9B
$61K 0.01%
+936
New +$65.5K
SWKS icon
412
Skyworks Solutions
SWKS
$10.6B
$60K 0.01%
+594
New +$61.8K
APC
413
DELISTED
Anadarko Petroleum
APC
$60K 0.01%
+995
New +$58.3K
APD icon
414
Air Products & Chemicals
APD
$67.6B
$59K 0.01%
+371
New +$61.2K
DVA icon
415
DaVita
DVA
$11.7B
$59K 0.01%
+893
New +$65.6K
XRX icon
416
Xerox
XRX
$425M
$59K 0.01%
+2,049
New +$63K
K
417
DELISTED
Kellanova
K
$58K 0.01%
+952
New +$60.1K
YUM icon
418
Yum! Brands
YUM
$41.1B
$58K 0.01%
+684
New +$56.1K
DHI icon
419
D.R. Horton
DHI
$42.3B
$56K 0.01%
+1,286
New +$60K
HWM icon
420
Howmet Aerospace
HWM
$112B
$56K 0.01%
+3,196
New +$65K
ICE icon
421
Intercontinental Exchange
ICE
$84.4B
$56K 0.01%
+768
New +$56.1K
RSG icon
422
Republic Services
RSG
$65.7B
$56K 0.01%
+851
New +$57K
CAG icon
423
Conagra Brands
CAG
$7.23B
$55K 0.01%
+1,490
New +$54.9K
CINF icon
424
Cincinnati Financial
CINF
$27.1B
$55K 0.01%
+743
New +$55.6K
D icon
425
Dominion Energy
D
$59.3B
$55K 0.01%
+814
New +$60.1K

Similar funds

Convergence Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.

  • Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
  • Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
  • Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
  • Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
  • Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
  • Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
  • Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.

Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.